Clinical trials in Anderlecht – page 8

432 clinical trials in Anderlecht, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Anderlecht at a glance

432

clinical trials

Research sites2

Quick filters

432 trials in Anderlecht

Open in trial search

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:Revolution Medicines Inc.

Contact Research Centre

Clear cell renal cell carcinoma

Recruiting

Registered drugNo placebo

Study of Lutetium-177-PSMA treatment for patients with advanced clear cell kidney cancer who had progression after first or second line therapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Lutetium (177Lu) Vipivotide Tetraxetan
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:IBUZATRELVIR
Sponsor:Pfizer Inc.

Contact Research Centre

Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Amphotericin B
Sponsor:Basilea Pharmaceutica International AG Allschwil

Contact Research Centre

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Investigational

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Dnth103
Sponsor:Dianthus Therapeutics Inc.

Contact Research Centre

Allogenic stem cell transplantation

Recruiting

Registered drugNo placebo

Study on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Centre Hospitalier Universitaire De Liege

Contact Research Centre

Autologous haematopoietic stem cell transplant

Recruiting

Registered drugNo placebo

Study Comparing Two Drug Combinations for Blood Cancer Patients: Rabbit Anti-Human Thymocyte Immunoglobulin vs. Anhydrous Cyclophosphamide

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Anhydrous Cyclophosphamide
Sponsor:Centre Hospitalier Universitaire De Liege

Contact Research Centre

Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART
Sponsor:Immunovant Sciences GmbH

Contact Research Centre

HER2 positive biliary tract cancer

Recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Investigational

Belgium

Participants:0–17 years · 18–64 years
Substances:Rilzabrutinib
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Anderlecht

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials investigating new treatments for various cancers, including bladder cancer, acute myeloid leukemia, and advanced breast cancer. Studies focus on innovative combination therapies and targeted treatments.

Non-muscle invasive bladder cancer therapy
Metastatic breast cancer treatments
Gastroesophageal cancer interventions

02 Immunology and Inflammatory Conditions

Clinical investigations targeting chronic inflammatory conditions and autoimmune disorders, including Crohn's Disease, Ulcerative Colitis, and Psoriatic Arthritis.

Inflammatory bowel disease therapies
Novel arthritis treatments
Sjögren's Disease interventions

03 Infectious Diseases

Studies examining innovative approaches to combat various infections, including urinary tract infections and viral diseases. Research includes vaccine development and antimicrobial therapies.

UTI vaccine development
RSV vaccination studies
Hepatitis D treatments

04 Cardiovascular and Pulmonary Studies

Research focusing on pulmonary hypertension and cardiovascular disease management, with emphasis on innovative therapeutic approaches and disease prevention.

Pulmonary arterial hypertension treatments
Cardiovascular disease interventions
Post-cardiac arrest care

Back to Belgium All countries

Clinical trials in Anderlecht – page 8

432 trials in Anderlecht

Hypertriglyceridaemia

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Non-small cell lung cancer

Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

Clear cell renal cell carcinoma

Study of Lutetium-177-PSMA treatment for patients with advanced clear cell kidney cancer who had progression after first or second line therapy

COVID-19

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Fungal infection+3

Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

Endometrial cancer

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Chronic inflammatory demyelinating polyradiculoneuropathy

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Allogenic stem cell transplantation

Study on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Autologous haematopoietic stem cell transplant

Study Comparing Two Drug Combinations for Blood Cancer Patients: Rabbit Anti-Human Thymocyte Immunoglobulin vs. Anhydrous Cyclophosphamide

Graves' disease

Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease

HER2 positive biliary tract cancer

Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

Sickle cell disease

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Filter the trials

Other cities in Belgium

Clinical research in Anderlecht

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Anderlecht – page 8

432 trials in Anderlecht

Fungal infection+3

Other cities in Belgium

Related

Clinical research in Anderlecht

Prefer not to search? Our Concierge searches the trials for you.